Literature DB >> 15492020

Multidrug transporter activity in lymphocytes.

James I Elliott1, Selina Raguz, Christopher F Higgins.   

Abstract

Multidrug transporters play a dual role in haematopoietic cells, mediating the efflux of xenobiotics and regulating cell migration. For several reasons including the lack of specific antibodies, reports of multidrug transporter distribution on lymphocytes conflict. Murine B cells have been reported to completely lack transporter activity. Through analysis of parental and 'knockout' mice we show that, contrary to previous studies, murine B and T lymphocytes possess at least three active multidrug transporters and also a hitherto unrecognised drug-specific import activity. Surprisingly, the drug specificity of P-glycoprotein appears cell type dependent. The data indicate that a range of developmentally regulated, multidrug transporters can impose a barrier to treatment of immune disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15492020      PMCID: PMC1575936          DOI: 10.1038/sj.bjp.0705940

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

Review 1.  The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy.

Authors:  P Borst; J Balzarini; N Ono; G Reid; H de Vries; P Wielinga; J Wijnholds; N Zelcer
Journal:  Antiviral Res       Date:  2004-04       Impact factor: 5.970

2.  Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.

Authors:  M A Ghetie; V Ghetie; E S Vitetta
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

3.  Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

Authors:  K Miyake; L Mickley; T Litman; Z Zhan; R Robey; B Cristensen; M Brangi; L Greenberger; M Dean; T Fojo; S E Bates
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

4.  The multidrug resistance protein 1: a functionally important activation marker for murine Th1 cells.

Authors:  S Prechtl; M Roellinghoff; R Scheper; S P Cole; R G Deeley; M Lohoff
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.

Authors:  S Dey; P Hafkemeyer; I Pastan; M M Gottesman
Journal:  Biochemistry       Date:  1999-05-18       Impact factor: 3.162

Review 6.  Multidrug resistance proteins in rheumatoid arthritis, role in disease-modifying antirheumatic drug efficacy and inflammatory processes: an overview.

Authors:  G Jansen; R J Scheper; B A C Dijkmans
Journal:  Scand J Rheumatol       Date:  2003       Impact factor: 3.641

7.  Multidrug resistance protein 1-mediated transport of saquinavir by microglia.

Authors:  Shannon Dallas; Patrick T Ronaldson; Moise Bendayan; Reina Bendayan
Journal:  Neuroreport       Date:  2004-05-19       Impact factor: 1.837

8.  Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.

Authors:  D Drach; S Zhao; J Drach; R Mahadevia; C Gattringer; H Huber; M Andreeff
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

9.  Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.

Authors:  P M Chaudhary; E B Mechetner; I B Roninson
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

10.  The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar.

Authors:  J C Taylor; D R Ferry; C F Higgins; R Callaghan
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

View more
  10 in total

Review 1.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

2.  ABCB1 polymorphism and susceptibility to acute lymphoblastic leukemia: a meta analysis.

Authors:  Haiyan Zhang; Zhen Zhang; Guang Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 3.  Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation.

Authors:  Camille Tron; Florian Lemaitre; Céline Verstuyft; Antoine Petitcollin; Marie-Clémence Verdier; Eric Bellissant
Journal:  Clin Pharmacokinet       Date:  2019-05       Impact factor: 6.447

4.  Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells.

Authors:  Paola Nieri; Nadia Romiti; Barbara Adinolfi; Andrea Chicca; Ilaria Massarelli; Elisabetta Chieli
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

5.  Role of the highly structured 5'-end region of MDR1 mRNA in P-glycoprotein expression.

Authors:  Rebecca A Randle; Selina Raguz; Christopher F Higgins; Ernesto Yagüe
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

6.  Expression of c-kit and Sca-1 and their relationship with multidrug resistance protein 1 in mouse bone marrow mononuclear cells.

Authors:  Fernanda Kyle-Cezar; Juliana Echevarria-Lima; Regina Coeli dos Santos Goldenberg; Vivian M Rumjanek
Journal:  Immunology       Date:  2007-05       Impact factor: 7.397

7.  Human Immunodeficiency Virus Persistence in the Spleen: Opportunities for Pharmacologic Intervention.

Authors:  Aaron S Devanathan; Angela D M Kashuba
Journal:  AIDS Res Hum Retroviruses       Date:  2021-02-22       Impact factor: 1.723

8.  ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysis.

Authors:  Limin Ma; Linhai Ruan; Hongchao Liu; Haiping Yang; Yanming Feng
Journal:  Onco Targets Ther       Date:  2015-05-05       Impact factor: 4.147

Review 9.  Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes.

Authors:  Mauro Cataldi; Chiara Vigliotti; Teresa Mosca; MariaRosaria Cammarota; Domenico Capone
Journal:  Int J Mol Sci       Date:  2017-06-10       Impact factor: 5.923

10.  Assessment of Plasmodium falciparum PfMDR1 transport rates using Fluo-4.

Authors:  O Friedrich; S J Reiling; J Wunderlich; P Rohrbach
Journal:  J Cell Mol Med       Date:  2014-06-01       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.